Hebei Changshan Biochemical Pharmaceutical Co Ltd banner

Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255

Watchlist Manager
Hebei Changshan Biochemical Pharmaceutical Co Ltd Logo
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Watchlist
Price: 41.42 CNY -3.11% Market Closed
Market Cap: ¥38.1B

Profitability Summary

Hebei Changshan Biochemical Pharmaceutical Co Ltd's profitability score is 19/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

19 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

19 / 100
Profitability
Score
19 / 100
Profitability
Score

Margins

Earnings Waterfall
Hebei Changshan Biochemical Pharmaceutical Co Ltd

Margins Comparison
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
38.1B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
887.6B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.2B USD
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
236.2B GBP
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.5B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
234.4B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.1B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
38.1B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
887.6B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.2B USD
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
236.2B GBP
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
234.4B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.1B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Hebei Changshan Biochemical Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett